farnesol has been researched along with Experimental Hepatoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Balaraman, G; Krishnan, P; Mari, A; Salam, S; Sirajduddin, I; Subramaniam, N; Sundaram, J; Thiruvengadam, D | 1 |
| Abarca, J; Borbath, I; Charette, N; De Saeger, C; Horsmans, Y; Leclercq, I; Schneider-Merck, T; Stärkel, P | 1 |
| da Silva Morais, A; Horsmans, Y; Leclercq, I; Saliez, A; Stärkel, P | 1 |
3 other study(ies) available for farnesol and Experimental Hepatoma
| Article | Year |
|---|---|
Farnesol alleviates diethyl nitrosamine induced inflammation and protects experimental rat hepatocellular carcinoma.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Diethylnitrosamine; Farnesol; Inflammation; Liver; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Oxidative Stress; Rats; Rats, Wistar | 2021 |
Ras inhibition in hepatocarcinoma by S-trans-trans-farnesylthiosalicyclic acid: association of its tumor preventive effect with cell proliferation, cell cycle events, and angiogenesis.
Topics: Animals; Anticarcinogenic Agents; Carcinogens; Cell Cycle; Cell Proliferation; Cyclin D; Diethylnitrosamine; Disease Models, Animal; Down-Regulation; Farnesol; Inflammation; Liver Neoplasms, Experimental; Male; Neovascularization, Pathologic; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-myc; ras Proteins; Rats; Rats, Wistar; Salicylates; STAT3 Transcription Factor | 2012 |
Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
Topics: Animals; Body Mass Index; Cell Cycle Proteins; Cell Membrane; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor Proteins; Cytosol; Farnesol; Gene Expression Regulation; Hepatectomy; Hepatocytes; Humans; Liver; Liver Neoplasms, Experimental; Male; MAP Kinase Signaling System; Oncogene Protein p21(ras); Organ Size; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; RNA, Messenger; Salicylates; Tumor Cells, Cultured | 2008 |